Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $38.4000 (-4.12%) ($38.0500 - $40.5500) on Thu. Sep. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 70 | Latest Price | $38.4000(-4.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.8% a day on average for past five trading days. | Weekly Trend | ATRA advances 4.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.64% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 0 () | Intraday Trend | -4.1% | | | |
|
5 Day Moving Average | $39.94(-3.86%) | 10 Day Moving Average | $39.58(-2.98%) | 20 Day Moving Average | $38.34(0.16%) | To recent high | -18.1% | To recent low | 9.6% | Market Cap | $2.853b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |